Epic Sciences: Jason Christiansen, Mark Aguillard, Amara Siva
Epic Sciences has appointed Jason Christiansen as chief technology officer, Mark Aguillard as VP and general manager of the oncology business unit, and Amara Siva as VP of laboratory operations.
Christiansen has 20 years of experience developing new technologies for research, clinical diagnostics, and new targeted therapy companion diagnostics. He has held executive positions at companies including Roche's sequencing solutions business, Boundless Bio, Ignyta, Genoptix, and HistoRx.
Aguillard previously led commercialization efforts at Myriad Genetics, Binx Health, OmniSeq, and Eli Lilly. He will drive Epic's commercial growth in the clinical oncology space.
Siva has more than 20 years of experience in the molecular diagnostics space and was in laboratory research and operations management at Pathnostics; Millennium Health; Genoptix (now part of NeoGenomics); Gen-Probe (now part of Hologic); and Alexion.